OPKO HEALTH, INC.
CIK 944809 · last filed 2024-08-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$529
Companies
3
Total Filings
34
Lifetime Open-Market Net
-$24.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGSWW | 10%+ Owner | 2,646,972 | $0.00 | $529 | -$24.70M | 12 | 2024-08-19 |
| VBI Vaccines Inc/BC (VBIV) Delisted | 10%+ Owner | 222,625 | $0.07 | $14.5K | $2.00M | 1 | 2017-11-01 |
| Sorrento Therapeutics, Inc. (SRNE) Delisted | 10%+ Owner | 2,161,759 | $0.00 | $1.1K | -$1.70M | 9 | 2013-11-27 |
Recent Filings · Page 3 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-11-25 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −8,471 | -$72.0K | EDGAR |
| 2013-11-22 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −4,269 | -$36.4K | EDGAR |
| 2013-11-21 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −17,062 | -$149.3K | EDGAR |
| 2013-11-18 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −2,710 | -$23.7K | EDGAR |
| 2013-11-15 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −1,900 | -$16.6K | EDGAR |
| 2013-11-14 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −13,457 | -$117.7K | EDGAR |
| 2013-11-12 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −2,000 | -$17.5K | EDGAR |
| 2013-11-08 | Sorrento Therapeutics, Inc. (SRNE) Delisted | Sell (S) | −120,380 | -$1.09M | EDGAR |
| 2013-09-04 | — | Sell (S) | −9,355 | -$72.5K | |
| 2013-08-30 | — | Sell (S) | −100 | -$775 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.